BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 25142598)

  • 1. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
    Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
    Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
    mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity.
    Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE
    J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
    Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
    J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
    McAllister N; Liu Y; Silva LM; Lentscher AJ; Chai W; Wu N; Griswold KA; Raghunathan K; Vang L; Alexander J; Warfield KL; Diamond MS; Feizi T; Silva LA; Dermody TS
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of Getah Virus by a Single Amino Acid Substitution at Residue 253 of the E2 Protein that Might Be Part of a New Heparan Sulfate Binding Site on Alphaviruses.
    Wang N; Zhai X; Li X; Wang Y; He WT; Jiang Z; Veit M; Su S
    J Virol; 2022 Mar; 96(6):e0175121. PubMed ID: 34986000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
    Acharya D; Paul AM; Anderson JF; Huang F; Bai F
    PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the E2 Glycoprotein and the 3' Untranslated Region Enhance Chikungunya Virus Virulence in Mice.
    Hawman DW; Carpentier KS; Fox JM; May NA; Sanders W; Montgomery SA; Moorman NJ; Diamond MS; Morrison TE
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28747508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chikungunya Virus Evades Antiviral CD8
    Davenport BJ; Bullock C; McCarthy MK; Hawman DW; Murphy KM; Kedl RM; Diamond MS; Morrison TE
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32102875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
    Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
    mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
    Weber C; Berberich E; von Rhein C; Henß L; Hildt E; Schnierle BS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005318. PubMed ID: 28114368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design.
    Gardner CL; Hritz J; Sun C; Vanlandingham DL; Song TY; Ghedin E; Higgs S; Klimstra WB; Ryman KD
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2719. PubMed ID: 24587470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.
    Gardner CL; Burke CW; Higgs ST; Klimstra WB; Ryman KD
    Virology; 2012 Apr; 425(2):103-12. PubMed ID: 22305131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4'-Fluorouridine inhibits alphavirus replication and infection
    Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
    mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein.
    Gorchakov R; Wang E; Leal G; Forrester NL; Plante K; Rossi SL; Partidos CD; Adams AP; Seymour RL; Weger J; Borland EM; Sherman MB; Powers AM; Osorio JE; Weaver SC
    J Virol; 2012 Jun; 86(11):6084-96. PubMed ID: 22457519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two Conserved Phenylalanine Residues in the E1 Fusion Loop of Alphaviruses Are Essential for Viral Infectivity.
    Lucas CJ; Davenport BJ; Carpentier KS; Tinega AN; Morrison TE
    J Virol; 2022 May; 96(9):e0006422. PubMed ID: 35416719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.